Effective HCPCS/MOD Special Notes Date Code Action Long Description (Any reference or xref code) Q5102 Add Injection, Infliximab, Biosimilar, 10 mg 7/1/2016 2049 Q9981 Add Rolapitant, oral, 1 mg 7/1/2016 Flutemetamol F18, diagnostic, per study Q9982 Add dose, up to 5 millicuries 7/1/2016 0189 Florbetaben f18, diagnostic, per study Q9983 Add dose, up to 8.1 millicuries 7/1/2016 0189 Colonoscopy consultation performed prior to a screening colonoscopy S0285 Add procedure 7/1/2016 Comprehensive management and care coordination for advanced illness, per S0311 Add calendar month 7/1/2016 Gene expression profiling panel for use Reinstatement of code originally in the management of breast cancer est. 1/1/2006; discontinued S3854 Add treatment 7/1/2016 12/31/15 ZB Add Pfizer/Hospira 7/1/2016
HCPCS/MOD Code Action Long Description Effective Date Special Notes (Any reference or xref code) Q5102 Add Injection, Infliximab, Biosimilar, 10 mg 7/1/2016 2049 Q9981 Add Rolapitant, oral, 1 mg 7/1/2016 Q9982 Add Flutemetamol F18, diagnostic, per study dose, up to 5 millicuries 7/1/2016 0189 Q9983 Add Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries 7/1/2016 0189 S0285 Add Colonoscopy consultation performed prior to a screening colonoscopy procedure 7/1/2016 S0311 Add Comprehensive management and care coordination for advanced illness, per calendar month 7/1/2016 S3854 Add Gene expression profiling panel for use in the management of breast cancer treatment 7/1/2016 Reinstatement of code originally est. 1/1/2006; discontinued 12/31/15 ZB Add Pfizer/Hospira 7/1/2016
2016-HCPCS-July-Updates.docx